FAQs | Site Map | Links | Home
January 13, 2009
skip navigation

  arrow Bill Tracking

  (spacer) Legislative Updates

  (spacer) Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH


  (spacer) OLPA


margin frame

Bill TrackingBill Tracking
(spacer)

House Bills - 108th Congress

arrow indicating current page Session I | Session II

H.R. 2021—Access to Clinical Trials

On May 7, 2003, Representative Deborah Pryce (R-OH) introduced H.R. 2021, the Access to Cancer Clinical Trials Act of 2003. The bill would amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide coverage for individuals participating in approved cancer clinical trials. H.R. 2021 was jointly referred to the House Committees on Energy and Commerce, on Education and the Workforce, and on Ways and Means.

Legislative Update (August 2004): Access to Clinical Trials

(spacer)

 

Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy